美国食品和药物管理局批准Pixclara用于治疗慢性干眼. FDA approves Pixclara for chronic dry eye treatment.

美国食品和药物管理局已接受TLX101-Px的新药申请,该药称为Pixclara®,用于治疗眼部表面疾病. The U.S. Food and Drug Administration has accepted the New Drug Application for TLX101-Px, known as Pixclara®, a treatment for ocular surface disease. 这一监管步骤使治疗更接近美国的慢性干眼患者. This regulatory step moves the therapy one step closer to potential U.S. availability for patients suffering from chronic dry eye.